Fund Holdings — ACUTA CAPITAL PARTNERS, LLC

Total Portfolio Value:
$86.23M
Total Bought:
$24.72M
Total Sold:
$26.53M
Net Transaction:
-$1.81M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Ocular Therapeutix, Inc.(OCUL)1,111,0711,219,724+108,653$9.49M$8.94M10.37%-$548.0K
Insmed Incorporated(INSM)104,800106,074+1,274$7.24M$8.09M9.38%+$857.0K
Tourmaline Bio Inc351,842426,882+75,040$7.14M$6.49M7.53%-$642.5K
Whitehawk Therapeutics, Inc.(WHWK)1,849,4023,410,402+1,561,000$5.83M$6.07M7.04%+$235.7K
Enliven Therapeutics Inc267,368265,269-2,099$6.02M$5.22M6.05%-$795.3K
Trevi Therapeutics, Inc.(TRVI)771,958785,961+14,003$3.18M$4.94M5.73%+$1.76M
Soleno Therapeutics Inc067,136+67,136$0$4.80M5.56%+$4.80M
argenx SEADR(ARGX)6,9107,023+113$4.25M$4.16M4.82%-$93.0K
Ascendis Pharma A/SADR(ASND)22,97623,340+364$3.16M$3.64M4.22%+$474.7K
Praxis Precision Medicines, Inc.(PRAX)67,50087,141+19,641$5.19M$3.30M3.83%-$1.89M
Cidara Therapeutics Inc54,473125,708+71,235$1.46M$2.71M3.14%+$1.24M
Oculis Holding AG(OCS)0125,000+125,000$0$2.38M2.76%+$2.38M
Revolution Medicines, Inc.(RVMD)111,70066,662-45,038$4.89M$2.36M2.73%-$2.53M
Liquidia Corporation(LQDA)137,709153,482+15,773$1.62M$2.26M2.63%+$644.4K
Bright Minds Biosciences Inc.(DRUG)69,12459,748-9,376$2.49M$2.16M2.50%-$334.7K
Helix Acquisition Corp IiCL A180,945187,257+6,312$1.90M$2.12M2.45%+$216.1K
Merck & Co., Inc.(MRK)022,994+22,994$0$2.06M2.39%+$2.06M
Surrozen, Inc.(SRZN)0170,000+170,000$0$1.98M2.30%+$1.98M
Edgewise Therapeutics, Inc.(EWTX)87,65885,454-2,204$2.34M$1.88M2.18%-$460.5K
Mereo BioPharma Group plcADS(MREO)779,308791,815+12,507$2.73M$1.78M2.07%-$946.0K
Unicycive Therapeutics Inc2,303,0002,352,887+49,887$1.83M$1.35M1.57%-$476.4K
Jazz Pharmaceuticals plcSHS USD(JAZZ)09,575+9,575$0$1.19M1.38%+$1.19M
Verastem, Inc.(VSTM)0176,000+176,000$0$1.06M1.23%+$1.06M
Gilead Sciences, Inc.(GILD)9,1509,298+148$845.2K$1.04M1.21%+$196.7K
Terns Pharmaceuticals Inc447,500325,550-121,950$2.48M$898.5K1.04%-$1.58M
Zymeworks Inc.(ZYME)67,24068,459+1,219$984.4K$815.3K0.95%-$169.0K
Ultragenyx Pharmaceutical Inc.(RARE)21,00021,290+290$883.5K$770.9K0.89%-$112.6K
Verve Therapeutics Inc160,200162,724+2,524$903.5K$743.6K0.86%-$159.9K
Rocket Pharmaceuticals, Inc.(RCKT)134,50083,350-51,150$1.69M$555.9K0.64%-$1.13M
Rapport Therapeutics, Inc.(RAPP)16,40016,4000$290.9K$164.5K0.19%-$126.4K
Forte Biosciences Inc18,13918,469+330$411.9K$143.3K0.17%-$268.6K
Artiva Biotherapeutics, Inc.(ARTV)44,00045,456+1,456$443.5K$136.4K0.16%-$307.2K
Nuvation Bio Inc.W EXP 07 07 2027(NUVB)90,83290,8320$20.9K$17.5K0.02%-$3.4K
Enliven Therapeutics Inc0115,805+115,805$0$0—$0
Arcellx Inc
COMMON STOCK
10,7430-10,743$823.9K$0—-$823.9K
Celcuity Inc.(CELC)25,0000-25,000$327.3K$0—-$327.3K
Corvus Pharmaceuticals, Inc.(CRVS)74,3070-74,307$397.5K$0—-$397.5K
Crinetics Pharmaceuticals In122,9000-122,900$6.28M$0—-$6.28M
Eledon Pharmaceuticals, Inc.N A(ELDN)235,7500-235,750$971.3K$0—-$971.3K
Mersana Therapeutics Inc1,120,5000-1,120,500$1.60M$0—-$1.60M
Newamsterdam Pharma Co Nv
ORDINARY SHARES
50,0000-50,000$1.28M$0—-$1.28M
Sangamo Therapeutics, Inc.(SGMOQ)740,0000-740,000$754.8K$0—-$754.8K
Taysha Gene Therapies, Inc.(TSHA)884,2440-884,244$1.53M$0—-$1.53M
Tectonic Therapeutic, Inc.(TECX)33,0080-33,008$1.52M$0—-$1.52M
Third Harmonic Bio Inc49,8000-49,800$512.4K$0—-$512.4K
Vaxcyte, Inc.(PCVX)45,0000-45,000$3.68M$0—-$3.68M
Page 1 of 1
ACUTA CAPITAL PARTNERS, LLC — 13F Holdings — Q1 2025 | TickerTrail